Skip to content

Biomarkers of Resilience in Stress Reduction for Caregivers of Alzheimer's Patients.

Lap Ho, Patricia A. Bloom, Joan G Vega, Shrishailam Yemul, Wei Zhao, Libby Ward, Evan Savage, Robert Rooney, Divyen H Patel, Giulio Maria Pasinetti

Neuromolecular medicine June 2016 DOI: 10.1007/s12017-016-8388-8 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pre-post intervention study (single-group) Peer reviewed
Sample size 20
Population Adult non-professional caregivers of dementia (Alzheimer's disease) patients
Intervention Mindfulness-based stress reduction (MBSR)
Duration 8-week MBSR training course
Topics Depression
Keywords Dementia Emotional distress Family caregiver Mindfulness-based stress reduction
Key points An 8-week MBSR course significantly improved psychological resilience in some caregivers of dementia patients, though not all benefited. Gene expression profiles of blood mononuclear cells identified biomarkers associated with the likelihood of benefiting from MBSR and with MBSR's psychological benefits, which the authors propose could inform a personalized-medicine approach to caregiver resilience.

Abstract

Caregiving for a dementia patient is associated with increased risk of psychological and physical health problems. We investigated whether a mindfulness-based stress reduction (MBSR) training course for caregivers that closely models the MBSR curriculum originally established by the Center of Mindfulness at the University of Massachusetts may improve the psychological resilience of non-professional caregivers of Alzheimer's disease patients. Twenty adult non-professional caregivers of dementia patients participated in an 8-week MBSR training course. Caregiver stress, depression, burden, grief, and gene expression profiles of blood mononuclear cells were assessed at baseline and following MBSR. MBSR training significantly improved the psychological resilience of some of the caregivers. We identified predictive biomarkers whose expression is associated with the likelihood of caregivers to benefit from MBSR, and biomarkers whose expression is associated with MBSR psychological benefits. Our biomarker studies provide insight into the mechanisms of health benefits of MBSR and a basis for developing a personalized medicine approach for applying MBSR for promoting psychological and cognitive resilience in caregivers of dementia patients.

Comparable studies

Other non-randomized and open-label trials on depression, most cited first.

Study Year Design Participants
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Patients with moderate-to-severe, unipolar, treatment-resistant major depression 2016 Open-label feasibility trial n = 12
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Patients with severe, unipolar, treatment-resistant major depression 2017 Open-label trial n = 20
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Patients with recurrent depression 2015 Open-label trial n = 17

Citations in the library

Explore topics